







Melanotan 1 (MT-1)
Melanotan 1 (also known as afamelanotide) from Super Human Peptides UK is a synthetic, linear peptide analogue of the naturally occurring alpha-melanocyte-stimulating hormone (alpha-MSH). In laboratory research, Melanotan 1 is studied for its ability to induce melanogenesis (the production of melanin) by acting as an agonist at the melanocortin 1 receptor (MC1R). Unlike its derivative, Melanotan 2, MT-1 is highly selective for the MC1 receptor, meaning researchers utilize it to study skin pigmentation and photoprotection pathways without the secondary central nervous system effects (such as appetite suppression or arousal) associated with broader melanocortin receptor activation.
Produced under GMP-compliant conditions and verified for 99% purity or higher, Melanotan 1 is a highly stable model for dermatological and UV-resistance research.
- —High Selectivity: Targeted agonist for the MC1 receptor (MC1R).
- —Linear Peptide Structure: Synthetic alpha-MSH analogue designed for longer half-life.
- —High Purity: 99% purity or higher (verified by HPLC and MS analysis).
- —Quality Standard: GMP / ISO certified manufacturing.
- —Melanogenesis: Studying the intracellular signalling pathways that lead to eumelanin production in melanocytes.
- —Phototoxicity Protection: Preclinical models investigating the peptide's ability to protect skin cells from UV-induced DNA damage.
- —Erythropoietic Protoporphyria (EPP) Models: Researching absolute light tolerance in genetically photosensitive animal models.
- —Receptor Selectivity: Comparing MC1R binding affinity against other melanocortin receptors (MC3R, MC4R).
- —Antioxidant Defence: Investigating secondary cellular responses to increased melanin concentrations.
Melanotan 1 has been extensively documented in clinical and preclinical literature under the generic name afamelanotide. Originally developed at the University of Arizona, laboratory studies demonstrated that administering MT-1 effectively mimics natural alpha-MSH but with a significantly longer half-life, allowing for sustained receptor activation. Research has shown that by stimulating MC1R, Melanotan 1 promotes the shift from pheomelanin (red/yellow pigment) to eumelanin (brown/black pigment), which provides superior photoprotection.
Due to its high specificity, it has become a foundational compound in studies related to preventing actinic keratosis, squamous cell carcinoma, and providing cellular defense in models of severe light intolerance.
- 1.Dorr, R.T. et al., "Evaluation of melanotan-I, a superpotent alpha-MSH analog," Life Sciences, 1996.
- 2.Hadley, M.E. et al., "Discovery and development of novel melanogenic drugs (Melanotan-I and -II)," Integration of Pharmaceutical Discovery and Development, 2006.
- 3.Biolcati, G. et al., "Efficacy of the melanocortin analogue Nle4-D-Phe7-alpha-MSH (afamelanotide) in erythropoietic protoporphyria," British Journal of Dermatology, 2015.
- 4.Abdel-Malek, Z.A. et al., "Alpha-MSH tripeptide analogs activate the melanocortin 1 receptor and reduce UV-induced DNA damage in human melanocytes," Pigment Cell & Melanoma Research, 2009.


